Failing FXR expression in the liver links aging to hepatic steatosis

Journal of Hepatology

Volumn 60, Issue 4, 2014, Pages 689-690

  Lefebvre, Philippe ^a,b,c   Staels, Bart ^d  

^a France   (France)

^b INSERM UMR1011 ^*  (France)

^c UNIV LILLE   (France)

^d INSTITUT PASTEUR DE LILLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FAT DROPLET; FOXM1B PROTEIN; FXR PROTEIN; HISTONE DEACETYLASE 1; LIVER PROTECTIVE AGENT; LIVER PROTEIN; OBETICHOLIC ACID; SIRTUIN 1; UNCLASSIFIED DRUG; CELL RECEPTOR; FARNESOID X-ACTIVATED RECEPTOR;

AGING; BILE ACID SYNTHESIS; CARDIOVASCULAR RISK; DOWN REGULATION; DRUG MECHANISM; DYSLIPIDEMIA; EDITORIAL; ELEVATED BLOOD PRESSURE; FATTY ACID OXIDATION; FATTY LIVER; HUMAN; INSULIN RESISTANCE; LIPID DEGRADATION; LIPID STORAGE; LIVER FUNCTION; LIVER REGENERATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; NONHUMAN; PHASE 2 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; ENDOPLASMIC RETICULUM STRESS; FEMALE; MALE; METABOLISM; NON-ALCOHOLIC FATTY LIVER DISEASE;

AGING; ANIMALS; ENDOPLASMIC RETICULUM STRESS; FEMALE; MALE; NON-ALCOHOLIC FATTY LIVER DISEASE; RECEPTORS, CYTOPLASMIC AND NUCLEAR;

EID: 84896400380     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2014.01.001     Document Type: Editorial

References (20)

1. C.M. Alexander, P.B. Landsman, and S.M. Grundy The influence of age and body mass index on the metabolic syndrome and its components Diabetes Obes Metab 10 2008 246 250
2. M. Gaggini, M. Morelli, E. Buzzigoli, R.A. DeFronzo, E. Bugianesi, and A. Gastaldelli Non-alcoholic fatty liver disease [NAFLD] and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart disease Nutrients 5 2013 1544 1560
3. A.P. Levene, and R.D. Goldin The epidemiology, pathogenesis and histopathology of fatty liver disease Histopathology 61 2012 141 152
4. M. Charlton Evolving aspects of liver transplantation for nonalcoholic steatohepatitis Curr Opin Organ Transplant 18 2013 251 258
5. A. Wree, L. Broderick, A. Canbay, H.M. Hoffman, and A.E. Feldstein From NAFLD to NASH to cirrhosis-new insights into disease mechanisms Nat Rev Gastroenterol Hepatol 10 2013 627 636
6. B.W. Smith, and L.A. Adams Nonalcoholic fatty liver disease and diabetes mellitus: pathogenesis and treatment Nat Rev Endocrinol 7 2011 456 465
7. C.P. Day, and O.F. James Steatohepatitis: a tale of two "hits"? Gastroenterology 114 1998 842 845
8. X. Xu, L.K. Hueckstaedt, and J. Ren Deficiency of insulin-like growth factor 1 attenuates aging-induced changes in hepatic function: role of autophagy J Hepatol 59 2013 308 317
9. M.J. Czaja Autophagy in health and disease 2. Regulation of lipid metabolism and storage by autophagy: pathophysiological implications Am J Physiol Cell Physiol 298 2010 C973 C978
10. U. Tomaru, S. Takahashi, A. Ishizu, Y. Miyatake, A. Gohda, and S. Suzuki et al. Decreased proteasomal activity causes age-related phenotypes and promotes the development of metabolic abnormalities Am J Pathol 180 2012 963 972
11. A.S. Moraes, A.M. Guaraldo, and M.L. Mello Chromatin supraorganization and extensibility in mouse hepatocytes with development and aging Cytometry A 71 2007 28 37
12. J. Jin, P. Iakova, Y. Jiang, E.E. Medrano, and N.A. Timchenko The reduction of SIRT1 in livers of old mice leads to impaired body homeostasis and to inhibition of liver proliferation Hepatology 54 2011 989 998
13. R.K. Minor, J.A. Baur, A.P. Gomes, T.M. Ward, A. Csiszar, and E.M. Mercken et al. SRT1720 improves survival and healthspan of obese mice Sci Rep 1 2011 70 10.1038/srep00070 [Epub@2011 Aug 18:70]
14. J. Jin, P. Iakova, M. Breaux, E. Sullivan, N. Jawanmardi, and D. Chen et al. Increased expression of enzymes of triglyceride synthesis is essential for the development of hepatic steatosis Cell Rep 3 2013 831 843
15. A. Erhuma, A.M. Salter, D.V. Sculley, S.C. Langley-Evans, and A.J. Bennett Prenatal exposure to a low-protein diet programs disordered regulation of lipid metabolism in the aging rat Am J Physiol Endocrinol Metab 292 2007 E1702 E1714
16. L. Vila, N. Roglans, M. Alegret, A. Camins, M. Pallas, and R.M. Sanchez et al. Hypertriglyceridemia and hepatic steatosis in senescence-accelerated mouse associate to changes in lipid-related gene expression J Gerontol A Biol Sci Med Sci 62 2007 1219 1227
17. S. Caron, S.C. Huaman, H. Dehondt, M. Ploton, O. Briand, and F. Lien et al. Farnesoid X receptor inhibits the transcriptional activity of carbohydrate response element binding protein in human hepatocytes Mol Cell Biol 33 2013 2202 2211
18. P. Lefebvre, B. Cariou, F. Lien, F. Kuipers, and B. Staels Role of bile acids and bile acid receptors in metabolic regulation Physiol Rev 89 2009 147 191
19. S. Mudaliar, R.R. Henry, A.J. Sanyal, L. Morrow, H.U. Marschall, and M. Kipnes et al. Efficacy and safety of the farnesoid X receptor agonist obeticholic acid in patients with type 2 diabetes and nonalcoholic fatty liver disease Gastroenterology 145 2013 574 582
20. W.D. Chen, Y.D. Wang, L. Zhang, S. Shiah, M. Wang, and F. Yang et al. Farnesoid X receptor alleviates age-related proliferation defects in regenerating mouse livers by activating forkhead box M1b transcription Hepatology 51 2010 953 962